The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Therapeutic strategies for rheumatoid arthritis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Self-citationAP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,572
Weinblatt, M. E., Kremer, J. M., Bankhurst, A. D., Bulpitt, K. J., Fleischmann, R. M., Fox, R. I., Jackson, C. G., Lange, M., & Burge, D. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400401 · Cited by 2,085
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A., & Chartash, E. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10697 · Cited by 1,757
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Self-citationTransgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Ravetch, J. V., & Bolland, S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,657
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Chernoff, M., Fried, B., Furst, D., Goldsmith, C., Kieszak, S., Lightfoot, R., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360601 · Cited by 1,640
Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Davis, D., MACFARLANE, J. D., Antoni, C., Leeb, B. F., Elliott, M. J., Woody, J. N., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9<1552::aid-art5>3.0.co;2-w · Cited by 1,623
Self-citationMoreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B., & van Venrooij, W. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1316 · Cited by 1,450
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., Klisak, I., Sparkes, R. S., Kubagawa, H., Mohandas, T., Quan, S., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90667-f · Cited by 1,327
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A., & O'Connor, P. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020696 · Cited by 1,242
INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Ipsky, P. E. E. L., Illiam, E. W., Urst, D. A. E. F., Reedveld, C. B., Oachim, J., Alden, R. K., Osef, J., Molen, S. S., Eisman, M. I. W., Mery, P. A. E., et al. (2000) · Cited by 1,155
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Thomson, A. W. (1994) · Cited by 1,116
Boers, M., Verhoeven, A. C., Markusse, H. M., van de Laar, M. A., Westhovens, R., van Denderen, J. C., van Zeben, D., Dijkmans, B. A., Peeters, A. J., Jacobs, P., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01300-7 · Cited by 1,073
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Epidemiology and genetics of rheumatoid arthritis.
Silman, A. J., & Pearson, J. E. (2002) · Arthritis Research · doi:10.1186/ar578 · Cited by 985
Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity
ELENKOV, I. J., & CHROUSOS, G. P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04229.x · Cited by 983
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Jovanović, D., Battista, J. A. D., Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Martel‐Pelletier, J. (1998) · PubMed · Cited by 973
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954
Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Pelletier, J.-P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3513 · Cited by 867
Möttönen, T., Hannonen, P., Leirisalo-Repo, M., Nissilä, M., Kautiainen, H., Korpela, M., Laasonen, L., Julkunen, H., Luukkainen, R., Vuori, K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08513-4 · Cited by 865
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N., Pav, S., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb770 · Cited by 833
Natalizumab for Active Crohn's Disease
Ghosh, S., Goldin, E., Gordon, F. H., Malchow, H. A., Rask-Madsen, J., Rutgeerts, P., Vyhnálek, P., Zádorová, Z., Palmer, T., & Donoghue, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020732 · Cited by 808
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.
Pettit, A. R., Ji, H., von Stechow, D., Müller, R., Goldring, S. R., Choi, Y., Benoist, C., & Gravallese, E. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63016-7 · Cited by 807
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS
Gabriel, S. E. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70201-5 · Cited by 782
Han, Z., Boyle, D. L., Chang, L., Bennett, B., Karin, M., Yang, L., Manning, A. M., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12466 · Cited by 780
Smolen, J. S., Kalden, J. R., Scott, D. L., Rozman, B., Kvien, T. K., Larsen, A., Loew-Friedrich, I., Oed, C., & Rosenburg, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09403-3 · Cited by 771
Self-citationHorai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
Schönbeck, U., Mach, F., & Libby, P. (1998) · PubMed · Cited by 681
O’Dell, J. R., Haire, C. E., Erikson, N., Drymalski, W., PALMER, W. R., Eckhoff, P. J., Garwood, V., Maloley, P. A., Klassen, L. W., Wees, S. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605163342002 · Cited by 654
Cohen, S., Hurd, E., Cush, J., Schiff, M., Weinblatt, M. E., Moreland, L. W., Kremer, J., Bear, M. B., Rich, W. J., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10141 · Cited by 638
A proinflammatory role for IL-18 in rheumatoid arthritis
Gracie, J. A., Forsey, R. J., Chan, W. L., Gilmour, A., Leung, B. P., Greer, M. R., Kennedy, K., Carter, R., Wei, X.-Q., Xu, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7317 · Cited by 636
Arthritis Provoked by Linked T and B Cell Recognition of a Glycolytic Enzyme
Matsumoto, I., Staub, A., Benoist, C., & Mathis, D. (1999) · Science · doi:10.1126/science.286.5445.1732 · Cited by 619
Gottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., & Krueger, J. G. (1995) · Nature Medicine · doi:10.1038/nm0595-442 · Cited by 606
Interleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604
Quantitative analysis of cytokine gene expression in rheumatoid arthritis.
Firestein, G. S., Alvaro-Gracia, J. M., & Maki, R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3347 · Cited by 598
Schönbeck, U., Mach, F., & Libby, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3340 · Cited by 595
Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades
Hubbard, A. K., & Rothlein, R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00223-9 · Cited by 594
Chu, C. Q., Field, M., Feldmann, M., & Maini, R. N. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340908 · Cited by 578
The paradigm of IL-6: from basic science to medicine.
Naka, T., Nishimoto, N., & Kishimoto, T. (2002) · Arthritis Research · doi:10.1186/ar565 · Cited by 566
Saxne, T., Palladino, M. A., Heinegãrd, D., Talal, N., & Wollheim, F. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310816 · Cited by 566
Toll receptors, CD14, and macrophage activation and deactivation by LPS
Dobrovolskaia, M. A., & Vogel, S. N. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01613-1 · Cited by 564
Van Der Heijde, D., Van Riel, P., Gribnau, F., Nuver-Zwart, I., & Van De Putte, L. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92442-2 · Cited by 556
Osteoclasts are essential for TNF-α–mediated joint destruction
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15582 · Cited by 531
Self-citationCharles, P. J., Elliott, M. J., Davis, D., Potter, A. R., Kalden, J. R., Antoni, C., Breedveld, F. C., Js, S., Eberl, G., DeWoody, K. L., et al. (1999) · PubMed · Cited by 531
Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis
Tugwell, P., Pincus, T., Yocum, D., Stein, M., Gluck, O., Kraag, G., McKendry, R., Tesser, J., Baker, P., & Wells, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330301 · Cited by 530
Choy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526
Gravallese, E. M., Harada, Y., Wang, J. T., Gorn, A. H., Thornhill, T. S., & Goldring, S. R. (1998) · Europe PMC (PubMed Central) · Cited by 516
McInnes, I. B., Leung, B. P., Sturrock, R. D., Field, M., & Liew, F. Y. (1997) · Nature Medicine · doi:10.1038/nm0297-189 · Cited by 512
Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response
Labasi, J. M., Petrushova, N., Donovan, C., McCurdy, S., Lira, P., Payette, M. M., Brissette, W., Wicks, J. R., Audoly, L., & Gabel, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6436 · Cited by 490
The effect of a single dose of osteoprotegerin in postmenopausal women.
Bekker, P. J., Holloway, D., Nakanishi, A., Arrighi, M., Leese, P. T., & Dunstan, C. R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.348 · Cited by 484
CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
Eastgate, J., Wood, N., Di Giovine, F., Symons, J., Grinlinton, F., & Duff, G. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90185-7 · Cited by 484
van der Heide, A., Jacobs, J. W. G., Bijlsma, J. W. J., Heurkens, A. H. M., van Booma-Frankfort, C., van der Veen, M. J., Haanen, H. C. M., & Hofman, D. M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-8-199604150-00001 · Cited by 480
Osteoclasts are essential for TNF-α-mediated joint destruction.
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215582 · Cited by 474
Self-citationCharles, P., Elliott, M. J., Davis, D., Potter, A., Kalden, J. R., Antoni, C., Breedveld, F. C., Smolen, J. S., Eberl, G., deWoody, K., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1521 · Cited by 436
Self-citationKonttinen, Y. T., Ainola, M., Valleala, H., Ma, J., Ida, H., Mandelin, J., Kinne, R. W., Santavirta, S., Sorsa, T., López-Otín, C., et al. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.11.691 · Cited by 403
Jiang, Y., Genant, H. K., Watt, I., Cobby, M., Bresnihan, B., Aitchison, R., & McCabe, D. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1001::aid-anr7>3.0.co;2-p · Cited by 399
Wolfe, F., & Hawley, D. J. (1998) · PubMed · Cited by 374
AP-1 and NF-kB Regulation in Rheumatoid Arthritis and Murine Collagen-Induced Arthritis
Han, Z., Boyle, D. L., Manning, A. M., & Firestein, G. S. (1998) · Autoimmunity · doi:10.3109/08916939808995367 · Cited by 369
ADAMTS: a novel family of extracellular matrix proteases
Tang, B. L. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00061-3 · Cited by 361
Kremer, J. M., Genovese, M. C., Cannon, G. W., Caldwell, J. R., Cush, J. J., Furst, D. E., Luggen, M. E., Keystone, E., Weisman, M. H., Bensen, W. M., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-9-200211050-00007 · Cited by 353
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
Regan, J., Breitfelder, S., Cirillo, P., Gilmore, T., Graham, A. G., Hickey, E., Klaus, B., Madwed, J., Moriak, M., Moss, N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020057r · Cited by 348
Krueger, G. G., Papp, K. A., Stough, D. B., Loven, K. H., Gulliver, W. P., & Ellis, C. N. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.127247 · Cited by 338
Pincus, T., Brooks, R. H., & Callahan, L. F. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00005 · Cited by 335
Pahl, H. L., Krauss, B., Schulze-Osthoff, K., Decker, T., Traenckner, E. B., Vogt, M., Myers, C., Parks, T., Warring, P., Mühlbacher, A., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1829 · Cited by 334
Pirvola, U., Xing-Qun, L., Virkkala, J., Saarma, M., Murakata, C., Camoratto, A. M., Walton, K. M., & Ylikoski, J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00043.2000 · Cited by 307
Endotoxin-induced serum factor that stimulates gamma interferon production
Nakamura, K., Okamura, H., Wada, M., Nagata, K., & Tamura, T. (1989) · Infection and Immunity · doi:10.1128/iai.57.2.590-595.1989 · Cited by 299
Dolhain, R. J. E. M., van der Heiden, A. N., ter Haar, N. T., Breedveld, F. C., & Miltenburg, A. M. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391204 · Cited by 295
Ruchatz, H., Leung, B. P. L., Wei, X., McInnes, I. B., & Liew, F. Y. (1998) · PubMed · Cited by 290
Awane, M., Andres, P. G., Li, D. J., & Reinecker, H. (1999) · PubMed · Cited by 288
Adhesion events in angiogenesis
Eliceiri, B. P., & Cheresh, D. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00252-0 · Cited by 287
Expression and Regulation of Toll-Like Receptor 2 in Rheumatoid Arthritis Synovium
Seibl, R., Birchler, T., Loeliger, S., Hossle, J. P., Gay, R. E., Saurenmann, T., Michel, B. A., Seger, R. A., Gay, S., & Lauener, R. P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63918-1 · Cited by 287
Weinblatt, M. E., Kremer, J. M., Coblyn, J. S., Maier, A. L., Helfgott, S. M., Morrell, M., Byrne, V. M., Kaymakcian, M. V., & Strand, V. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199907)42:7<1322::aid-anr4>3.0.co;2-p · Cited by 286
Redlich, K., Hayer, S., Maier, A., Dunstan, C. R., Tohidast‐Akrad, M., Lang, S., Türk, B., Pietschmann, P., Woloszczuk, W., Haralambous, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10097 · Cited by 285
Self-citationSmolen, J. S., Eberl, G., Breedveld, F. C., Jones, I., Leeming, M., Wylie, G. L., & Kirkpatrick, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380106 · Cited by 285
Self-citationActivation and inhibition of lymphocytes by costimulation
Frauwirth, K. A., & Thompson, C. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214941 · Cited by 283
Sharp, J. T., Strand, V., Leung, H., Hurley, F., & Loew-Friedrich, I. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<495::aid-anr4>3.0.co;2-u · Cited by 278
The balance of Th1/Th2 cytokines in rheumatoid arthritis
Schulze-Koops, H., & Kalden, J. R. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0187 · Cited by 275
Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.
Wendling, D., Racadot, E., & Wijdenes, J. (1993) · PubMed · Cited by 274
Collagenase Production by Rheumatoid Synovial Cells: Stimulation by a Human Lymphocyte Factor
Dayer, J.-M., Russell, R. G. G., & Krane, S. M. (1977) · Science · doi:10.1126/science.188134 · Cited by 274
Awane, M., Andres, P. G., Li, D. J., & Reinecker, H.-C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5337 · Cited by 272
Metalloproteases and inhibitors in arthritic diseases
Martel-Pelletier, J., Welsch, D. J., & Pelletier, J.-P. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0195 · Cited by 270
Kavanaugh, A. F., Davis, L. S., Nichols, L. A., Norris, S. H., Rothlein, R., Scharschmidt, L. A., & Lipsky, P. E. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370703 · Cited by 263
Dougados, M., Combe, B., Cantagrel, A., Goupille, P., Olive, P., Schattenkirchner, M., Meusser, S., Paimela, L., Rau, R., Zeidler, H., et al. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.4.220 · Cited by 259
Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength
Chellaiah, M., Kizer, N., Silva, M., Alvarez, U., Kwiatkowski, D., & Hruska, K. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.665 · Cited by 257
Induction and Suppression of Collagen-Induced Arthritis Is Dependent on Distinct Fcγ Receptors
Kleinau, S., Martinsson, P., & Heyman, B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1611 · Cited by 255
Vita, S. D., Zaja, F., Sacco, S., Candia, A. D., Fanin, R., & Ferraccioli, G. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10467 · Cited by 251
van Gestel, A. M., Anderson, J. J., van Riel, P. L. C. M., Boers, M., HAAGSMA, C. J., Rich, B., Wells, G. A., Lange, M., & Felson, D. T. (1999) · PubMed · Cited by 250
Ruuls, S. R., Hoek, R. M., Ngo, V. N., McNeil, T., Lucian, L. A., Janatpour, M. J., Körner, H., Scheerens, H., Hessel, E. M., Cyster, J. G., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00215-1 · Cited by 246
Plater-Zyberk, C., Joosten, L. A. B., Helsen, M. M. A., Sattonnet-Roche, P., Siegfried, C., Alouani, S., van de Loo, F. A. J., Graber, P., Aloni, S., Cirillo, R., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12097 · Cited by 240
Yelin, E., & Wanke, L. A. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1209::aid-anr18>3.0.co;2-m · Cited by 238
Toll-like receptors as potential therapeutic targets for multiple diseases
Zuany-Amorim, C., Hastewell, J., & Walker, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd914 · Cited by 233
Okamoto, H., Yamamura, M., Morita, Y., Harada, S., Makino, H., & Ota, Z. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400614 · Cited by 233
Wilder, R. L. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii96 · Cited by 232
Haagsma, C. J., van Riel, P. L., de Jong, A. J., & van de Putte, L. B. (1997) · Rheumatology · doi:10.1093/rheumatology/36.10.1082 · Cited by 231
Cytokine production by synovial T cells in rheumatoid arthritis
Steiner, G. (1999) · Rheumatology · doi:10.1093/rheumatology/38.3.202 · Cited by 228
Self-citationEggelmeijer, F., Papapoulos, S. E., van Paassen, H. C., Dijkmans, B. A. C., Valkema, R., Westedt, M. L., Landman, J., Pauwels, E. K. J., & Breedveld, F. C. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390307 · Cited by 227
Chemokines, chemokine receptors and small-molecule antagonists: recent developments
Onuffer, J. J., & Horuk, R. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02064-3 · Cited by 221
Zvaifler, N. J., & Firestein, G. S. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370601 · Cited by 221
Ruchatz, H., Leung, B. P., Wei, X.-Q., McInnes, I. B., & Liew, F. Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5654 · Cited by 219
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson, S. B. (2002) · Rheumatology · doi:10.1093/rheumatology/41.9.972 · Cited by 217
Choy, E. H. S. (2002) · Rheumatology · doi:10.1093/rheumatology/41.10.1133 · Cited by 213
The costs of rheumatoid arthritis: an international long-term view
Pugner, K. M., Scott, D. I., Holmes, J. W., & Hieke, K. (2000) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(00)80017-7 · Cited by 211
Manna, S. K., & Aggarwal, B. B. (1999) · PubMed · Cited by 208
Bruton's Tyrosine Kinase Links the B Cell Receptor to Nuclear Factor κb Activation
Bajpai, U. D., Zhang, K., Teutsch, M., Sen, R., & Wortis, H. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1735 · Cited by 208
Reduced Incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18
Wei, X.-Q., Leung, B. P., Arthur, H. M. L., McInnes, I. B., & Liew, F. Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.517 · Cited by 207
Autoantibodies in rheumatoid arthritis and their clinical significance.
Steiner, G. E., & Smolen, J. S. (2002) · Arthritis Research · doi:10.1186/ar551 · Cited by 204
Self-citationMacKay, K., Eyre, S., Myerscough, A., Milicic, A., Barton, A., Laval, S., Barrett, J., Lee, D., White, S., John, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10147 · Cited by 200
Chabaud, M., & Miossec, P. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1293::aid-art221>3.0.co;2-t · Cited by 197
Fantuzzi, G., Puren, A. J., Harding, M. W., Livingston, D. J., & Dinarello, C. A. (1998) · Blood · doi:10.1182/blood.v91.6.2118 · Cited by 196
Toll-like receptors: a family of pattern-recognition receptors in mammals.
Armant, M. A., & Fenton, M. J. (2002) · Genome biology · doi:10.1186/gb-2002-3-8-reviews3011 · Cited by 196
CD28/CTLA-4 and CD80/CD86 families: Signaling and function
Slavik, J. M., Hutchcroft, J. E., & Bierer, B. E. (1999) · Immunologic Research · doi:10.1007/bf02786473 · Cited by 196
Liverton, N. J., Butcher, J. W., Claiborne, C. F., Claremon, D. A., Libby, B. E., Nguyen, K. T., Pitzenberger, S. M., Selnick, H. G., Smith, G. R., Tebben, A., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9805236 · Cited by 196
Mahajan, S., Ghosh, S., Sudbeck, E. A., Zheng, Y., Downs, S., Hupke, M., & Uckun, F. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9587 · Cited by 191
Manna, S. K., & Aggarwal, B. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2095 · Cited by 187
Jackson, J. R., Bolognese, B., Hillegass, L., Kassis, S., Adams, J., Griswold, D. E., & Winkler, J. D. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37283-0 · Cited by 174
Siemasko, K., Chong, A. S.-F., Jäck, H.-M., Gong, H., Williams, J. W., & Finnegan, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1581 · Cited by 174
Weber, C. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0391-x · Cited by 173
Minocycline in active rheumatoid arthritis
Kloppenburg, M., Breedveld, F. C., Terwiel, J. P. H., Mallee, C., & Dijkmans, B. A. C. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370505 · Cited by 172
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis
ten Wolde, S., Breedveld, F. C., Dijkmans, B. A. C., Hermans, J., Vandenbroucke, J. P., van de Laar, M. A. F. J., Markusse, H. M., Janssen, M., & van den Brink, H. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90535-8 · Cited by 161
RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase
Wadsworth, S. A., CAVENDER, D. E., Beers, S. A., Lalan, P., Schafer, P. H., Malloy, E. A., Wu, W., Fahmy, B., Olini, G. C., Davis, J. E., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35155-9 · Cited by 157
Local production of complement proteins in rheumatoid arthritis synovium
Neumann, E., Barnum, S. R., Tarner, I. H., Echols, J., Fleck, M., Judex, M., Kullmann, F., Mountz, J. D., Schölmerich, J., Gay, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10183 · Cited by 155
Kraan, M. C., van Kuijk, A. W. R., Dinant, H. J., Goedkoop, A. Y., Smeets, T. J. M., de Rie, M. A., Dijkmans, B. A. C., Vaishnaw, A. K., Bos, J. D., & Tak, P. P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10543 · Cited by 150
Badger, A. M., Cook, M. N., Lark, M. W., Newman‐Tarr, T., Swift, B. A., Nelson, A. H., Barone, F. C., & Kumar, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.467 · Cited by 149
Horwood, N. J., Mahon, T., McDaid, J., Campbell, J., Mano, H., Brennan, F. M., Webster, D., & Foxwell, B. M. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021845 · Cited by 145
Alexopoulou, L., Pasparakis, M., & Kollias, G. A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271018 · Cited by 141
Mori, T., Wang, X., Aoki, T., & Lo, E. H. (2002) · Journal of Neurotrauma · doi:10.1089/089771502320914642 · Cited by 129
Santiago‐Schwarz, F., Anand, P., Liu, S. T. H., & Carsons, S. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1758 · Cited by 127
Kavanaugh, A. F., Davis, L. S., Jain, R. I., Nichols, L. A., Norris, S. H., & Lipsky, P. E. (1996) · PubMed · Cited by 127
Fürst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Antoni, C., Bijlsma, J. W. J., Burmester, G. R., Cronstein, B. N., Keystone, E. C., Kavanaugh, A., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii2 · Cited by 126
Self-citationWilliams, L. M., Gibbons, D. L., Gearing, A. J. H., Maini, R. N., Feldmann, M., & Brennan, F. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118739 · Cited by 122
Bombara, M., Webb, D. L., Conrad, P. J., Marior, C. W., Sarr, T., Ranges, G. E., Aune, T. M., Grave, J. M., & Blue, M. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.5.399 · Cited by 118
Isler, P., Vey, E., Zhang, J., & Dayer, J. (1993) · PubMed · Cited by 118
Interleukin‐1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid
Miossec, P., Dinarello, C. A., & Ziff, M. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290402 · Cited by 117
Ku, G., Faust, T., Lauffer, L. L., et al. (1996) · Cytokine · doi:10.1006/cyto.1996.0052 · Cited by 111
Heikkilä, P., Teronen, O. P., Moilanen, M., Konttinen, Y. T., Hanemaaijer, R., Laitinen, M., Maisi, P. S., van der Pluijm, G., Bartlett, J. D., Salo, T. A., et al. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200203000-00006 · Cited by 109
DellʼAntonio, G., Quattrini, A., Cin, E. D., Fulgenzi, A., & Ferrero, M. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10678 · Cited by 108
Sone, H., Kawakami, Y., Sakauchi, M., Nakamura, Y., Takahashi, A., Shimano, H., Okuda, Y., Segawa, T., Suzuki, H., & Yamada, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4395 · Cited by 107
Matrix metalloproteinase inhibitors in rheumatic diseases
Close, D. R. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.90003.iii62 · Cited by 104
Perregaux, D. G., & Gabel, C. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2469 · Cited by 103
Mukhopadhyay, S., Mohanty, M. C., Mangla, A. G., George, A., Bal, V., Rath, S., & Ravindran, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2914 · Cited by 101
HLA molecules, bacteria and autoimmunity
Ebringer, A., & WILSON, C. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-4-305 · Cited by 101
Fijen, J. W., Zijlstra, J. G., Boer, P. D., Spanjersberg, R., Tervaert, J.-W. C., van der Werf, T. S., Ligtenberg, J. J. M., & Tulleken, J. E. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01485.x · Cited by 101
Rutgeerts, P., Lemmens, L., Assche, G. V., Noman, M., Borghini-Fuhrer, I., & Goedkoop, R. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01414.x · Cited by 98
Newton, R. C., Solomon, K. A., Covington, M. B., Decicco, C. P., Haley, P. J., Friedman, S., & Vaddi, K. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.90003.iii25 · Cited by 97
Kavanaugh, A. F., Schulze‐Koops, H., Davis, L. S., & Lipsky, P. E. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400511 · Cited by 97
Perregaux, D. G., & Gabel, C. A. (1998) · PubMed · Cited by 96
Macrophage activation by T cells: cognate and non-cognate signals
Stout, R. D. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90059-2 · Cited by 91
Butler, D. M., Malfait, A., Maini, R. N., Brennan, F. M., & Feldmann, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199907)29:07<2205::aid-immu2205>3.0.co;2-z · Cited by 91
ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs
Randle, J. C. R., Harding, M. W., Ku, G., Schönharting, M., & Kurrle, R. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.7.1207 · Cited by 90
Coxon, A., Bolon, B. N., Estrada, J., Kaufman, S., Scully, S. A., Rattan, A., Duryea, D., Hu, Y., Rex, K. L., Pacheco, E., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10546 · Cited by 89
Essential role of T cell NF-kappa B activation in collagen-induced arthritis.
Seetharaman, R., Mora, A. L., Nabozny, G. H., Boothby, M. R., & Chen, J. (1999) · PubMed · Cited by 88
Is NF-κB a useful therapeutic target in rheumatoid arthritis?
Feldmann, M., Andreakos, E., Smith, C., Bondeson, J., Yoshimura, S., Kiriakidis, S., Monaco, C. G., Gasparini, C., Sacre, S. M., Lundberg, A. M., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii13 · Cited by 87
Biological aspects of signal transduction by cell adhesion receptors
Alahari, S. K., Reddig, P. J., & Juliano, R. L. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)20005-4 · Cited by 86
McLay, I. M., Halley, F., Souness, J. E., McKenna, J. M., Benning, V., Birrell, M. A., Burton, B., Belvisi, M. G., Collis, A. J., Constan, A. A., et al. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00331-x · Cited by 86
Genes on the X chromosome affect development of collagen-induced arthritis in mice
Jansson, L., & Holmdahl, R. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb08218.x · Cited by 83
Altered Memory T Cell Differentiation in Patients with Early Rheumatoid Arthritis
Skapenko, A., Wendler, J., Lipsky, P. E., Kalden, J. R., & Schulze‐Koops, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.491 · Cited by 79
Role of interleukin 15 and interleukin 18 in inflammatory response
Liew, F. Y., & McInnes, I. B. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii100 · Cited by 78
Ohta, S., Harigai, M., Tanaka, M., Kawaguchi, Y., Sugiura, T., Takagi, K., Fukasawa, C., Hara, M., & Kamatani, N. (2001) · PubMed · Cited by 77
VX-745. Vertex Pharmaceuticals.
Haddad, J. J. (2001) · PubMed · Cited by 77
Essential Role of T Cell NF-κB Activation in Collagen-Induced Arthritis
Seetharaman, R., Mora, A. L., Nabozny, G. H., Boothby, M. R., & Chen, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1577 · Cited by 76
Dedrick, R. L., Walicke, P. A., & Garovoy, M. R. (2002) · Transplant Immunology · doi:10.1016/s0966-3274(02)00029-1 · Cited by 75
Conway, J. G., Andrews, R. C., Beaudet, B., Bickett, D. M., Boncek, V. M., Brodie, T. A., Clark, R. L., Crumrine, R. C., Leenitzer, M. A., McDougald, D. L., et al. (2001) · PubMed · Cited by 75
Control of Autoimmunity by Regulatory T Cells
Shevach, E. M., McHugh, R. S., Thornton, A. M., Piccirillo, C. A., Natarajan, K., & Margulies, D. H. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1243-1_3 · Cited by 72
Electron microscopic demonstration of immunoglobulin deposition in rheumatoid cartilage
Ishikawa, H., Smiley, J. D., & Ziff, M. (1975) · Arthritis & Rheumatism · doi:10.1002/art.1780180606 · Cited by 72
Fritsch-Stork, R. D. E., Eselböck, D., Skriner, K., Jahn‐Schmid, B., Scheinecker, C., Bohle, B., Tohidast-Akrad, M., Hayer, S., Neumüller, J., Piñol-Roma, S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1068 · Cited by 72
Self-citationPintus, G., Tadolini, B., Posadino, A. M., Sanna, B., Debidda, M., Bennardini, F., Sava, G., & Ventura, C. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03307.x · Cited by 71
Nabbe, K. C., Blom, A. B., Holthuysen, A. E. M., Boross, P., Roth, J., Verbeek, S. J., van Lent, P. L. E. M., & van den Berg, W. B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10721 · Cited by 69
The Role of T-lymphocytes and Cytokines in Rheumatoid Arthritis
Smolen, J. S., Tohidast-Akrad, M., Gal, A., Kunaver, M., Eberl, G., Zenz, P., Falus, A., & Steiner, G. E. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609082660 · Cited by 64
Self-citationChoy, E. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.10.1142 · Cited by 58
Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis
Bolon, B. N., Shalhoub, V., Kostenuik, P. J., Campagnuolo, G., Morony, S., Boyle, W. J., Zack, D. J., & Feige, U. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10680 · Cited by 57
Naturally occurring and synthetic inhibitors of NF-kappaB functions.
Umezawa, K., Ariga, A., & Matsumoto, N. (2000) · PubMed · Cited by 56
Olsen, N. J., Brooks, R. H., Cush, J. J., Lipsky, P. E., Clair, E. W. S., Matteson, E. L., Gold, K. N., Cannon, G. W., Jackson, C. G., McCune, W. J., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390705 · Cited by 56
Efficacy of Methotrexate in Rheumatoid Arthritis
Weinblatt, M. E. (1995) · Lara D. Veeken · doi:10.1093/rheumatology/xxxiv.suppl_4.43 · Cited by 53
Yorgin, P. D., Hartson, S. D., Fellah, A. M., Scroggins, B. T., Huang, W., Katsanis, E., Couchman, J. M., Matts, R. L., & Whitesell, L. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2915 · Cited by 52
Beck, G., Bottomley, G. A., Bradshaw, D. J., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.390 · Cited by 52
Moreland, L. W., Gugliotti, R., King, K., Chase, W. F., Weisman, M. H., Greco, T., Fife, R. S., Korn, J. H., Simms, R. W., Tesser, J., et al. (2001) · Arthritis Research & Therapy · doi:10.1186/ar309 · Cited by 48
Jovanović, D., Battista, J. A. D., Martel‐Pelletier, J., Reboul, P., He, Y., Jolicoeur, F. C., & Pelletier, J. (2001) · PubMed · Cited by 47
Brühl, H., Cihak, J., Stangassinger, M., Schlöndorff, D., & Mack, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2420 · Cited by 42
Cited by
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Self-citationSmolen, J. S., Aletaha, D., Barton, A., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,445
Self-citationDickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Self-citationAbatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
Genovese, M. C., Becker, J.-C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C., Box, J., Natarajan, K., Nuamah, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050524 · Cited by 1,241
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197
Metadata
- Authors
- Smolen, J. S., & Steiner, G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-06-01
- Volume
- 2
- Issue
- 6
- Pages
- 473-488
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2149026148
- Cited by
- 911
- References
- 210
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.